Petros Christopoulos

Comutations and KRASG12C Inhibitor Efficacy in Advanced NSCLC

Marcelo V. Negrão, Haniel A. Araújo, Giuseppe Lamberti et al. · Cancer Discovery · 2023 · 181 citations · Full text

Medicine, Molecular Genetics, Oncology +17

Optimizing panel-based tumor mutational burden (TMB) measurement

Michael Allgäuer, Kevin Litchfield, Eugen Rempel et al. · Annals of Oncology · 2019 · 160 citations

Medicine, Bioinformatics, Oncology +12

Size matters: Dissecting key parameters for panel‐based tumor mutational burden analysis

Ivo Buchhalter, Eugen Rempel, Volker Endris et al. · International Journal of Cancer · 2018 · 158 citations

Medicine, Cancer Biology, Oncology +17

AURKA, DLGAP5, TPX2, KIF11 and CKAP5: Five specific mitosis-associated genes correlate with poor prognosis for non-small cell lung cancer patients

Marc A. Schneider, Petros Christopoulos, Thomas Muley et al. · International Journal of Oncology · 2017 · 147 citations · Full text

Life Sciences, Molecular Biology, Oncology +17

Interferon-stimulated neutrophils as a predictor of immunotherapy response

Madeleine Benguigui, Tim J. Cooper, Prajakta Kalkar et al. · Cancer Cell · 2024 · 147 citations · Full text

Medicine, Immunology, Oncology +17